Page 1 | Search Results | Blood | American Society of Hematology

1-14 of 14

Sort by

Sort Order Select

Journal Articles

A Mouse Model of CD19 CAR - T Cell Therapy Reveals Mechanism of Cytopenia

Bartosz Grzywacz, Ashenafi Tilahun, Irena Wilson, Kevin Welk, Bruce R Blazar, Christopher A Pennell

Blood (2023) 142 (Supplement 1): 3460.

https://doi.org/10.1182/blood-2023-190175

Published: 2023

Journal Articles

Proteomic and Transcriptomic Profiling Reveals Insights into Mechanisms of Leukemic Immune Escape

Sean I. Tracy, Hrishi Venkatesh, Miriam Arroyo, Todd Knutson, Ashenafi Tilahun, Bartosz Grzywacz, Michael Farrar

Blood (2022) 140 (Supplement 1): 6341–6342.

https://doi.org/10.1182/blood-2022-170683

Published: 2022

Journal Articles

Gda-201, a Novel Metabolically Enhanced Allogeneic Natural Killer (NK) Cell Product Yields High Remission Rates in Patients with Relapsed/Refractory Non-Hodgkin Lymphoma (NHL): 2-Year Survival and Correlation with Cytokine IL7

Veronika Bachanova, Joseph E. Maakaron, Frank Cichocki, David H. McKenna, Qing Cao, Todd E. DeFor, Murali Janakiram, Rose Wangen, Zuzan Cayci, Bartosz Grzywacz, Ronit Simantov, Tracey Lodie, Jeffrey S. Miller

Blood (2021) 138 (Supplement 1): 3854.

https://doi.org/10.1182/blood-2021-149989

Published: 2021

Journal Articles

Results of a Phase 1 Trial of Gda-201, Nicotinamide-Expanded Allogeneic Natural Killer (NK) Cells in Patients with Refractory Non-Hodgkin Lymphoma (NHL) and Multiple Myeloma

Veronika Bachanova, MD PhD, Joseph Maakaron, MD, David H. McKenna, MD, Qing Cao, MS, Todd E. DeFor, MS, Fiona He, MD, Murali Janakiram, MD, Rose Wangen, Zuzan Cayci, MD, Bartosz Grzywacz, MD, Ronit Simantov, MD, Tracey Lodie, PhD, Jeffrey S. Miller, MD

Blood (2020) 136 (Supplement 1): 6.

https://doi.org/10.1182/blood-2020-142419

Published: 2020

Journal Articles

Results of a Phase 1 Trial of Gda-201, Nicotinamide-Expanded Allogeneic Natural Killer Cells (NAM-NK) in Patients with Refractory Non-Hodgkin Lymphoma (NHL) and Multiple Myeloma (MM)

Veronika Bachanova, MD PhD, David H. McKenna, MD, Xianghua Luo, PhD, Todd E. DeFor, MS, Fiona He, MD, Murali Janakiram, MD MS, Erica D. Warlick, MD, Rose Wangen, Zuzan Cayci, MD, Bartosz Grzywacz, MD, Guy Brachya, PhD, Tony Peled, MSc, Jeffrey S. Miller, MD

Blood (2019) 134 (Supplement_1): 777.

https://doi.org/10.1182/blood-2019-130476

Published: 2019

Journal Articles

NK Cell Homing and Persistence in Bone Marrow after Adoptive Immunotherapy Correlates with Therapy Response

Bartosz Grzywacz, MD, Elizabeth L. Courville, MD, David H. McKenna, MD, Jeffrey S. Miller, MD, Sarah Cooley, MD, Laura Moench, MD

Blood (2017) 130 (Supplement 1): 4459.

https://doi.org/10.1182/blood.V130.Suppl_1.4459.4459

Published: 2017

Journal Articles

Specific KIR and HLA Genotypes Affect Outcomes Of Single-Agent Anti-CD20 Immunotherapy Of Follicular Lymphoma

Bartosz Grzywacz, MD, Amy K Erbe, PhD, Wei Wang, BS, Erik A. Ranheim, MD, PhD, Jacquelyn A Hank, PhD, KyungMann Kim, PhD, Lakeesha Carmichael, MS, Songwon Seo, MS, Eneida A Mendonca, MD, PhD, Yiqiang Song, MS, Fangxin Hong, PhD, Randy D. Gascoyne, MD, Elisabeth Paietta, PhD, Sandra J. Horning, MD, Brad S. Kahl, MD, Paul M Sondel, MD, PhD

Blood (2013) 122 (21): 507.

https://doi.org/10.1182/blood.V122.21.507.507

Published: 2013

Journal Articles

Natural killer–cell differentiation by myeloid progenitors

Bartosz Grzywacz, Nandini Kataria, Niketa Kataria, Bruce R. Blazar, Jeffrey S. Miller, Michael R. Verneris

Blood (2011) 117 (13): 3548–3558.

https://doi.org/10.1182/blood-2010-04-281394

Published: 2011

Includes: Supplemental data

Journal Articles

Limited role of MHC class I chain–related gene A (MICA) typing in assessing graft-versus-host disease risk after fully human leukocyte antigen–matched unrelated donor transplantation

Eric Anderson, Bartosz Grzywacz, Hongbo Wang, Tao Wang, Michael Haagenson, Stephen Spellman, Bruce R. Blazar, Jeffrey S. Miller, Michael R. Verneris

Blood (2009) 114 (21): 4753–4754.

https://doi.org/10.1182/blood-2009-08-239301

Published: 2009

Includes: Supplemental data

Journal Articles

Human embryonic stem cells differentiate into a homogeneous population of natural killer cells with potent in vivo antitumor activity

Petter S. Woll, Bartosz Grzywacz, Xinghui Tian, Rebecca K. Marcus, David A. Knorr, Michael R. Verneris, Dan S. Kaufman

Blood (2009) 113 (24): 6094–6101.

https://doi.org/10.1182/blood-2008-06-165225

Published: 2009

Includes: Supplemental data

Journal Articles

Identification of a Myeloid Pathway of NK Cell Development and a Myeloid- NK Cell Precursor

Bartosz Grzywacz, MD, Nandini Kataria, BS, Bruce R. Blazar, MD, Jeffrey S. Miller, MD, Michael Verneris, MD

Blood (2008) 112 (11): 103.

https://doi.org/10.1182/blood.V112.11.103.103

Published: 2008

Journal Articles

Umbilical Cord Blood T Cells Express the Natural Cytotoxicity Receptors, NKp30, NKp44 and NKp46 after IL-15 Stimulation, but Only NKp30 Is Functional.

Qin Tang, MS, Bartosz Grzywacz, MD, Hongbo Wang, PhD, Nandini Kataria, BS, John E. Wagner, MD, Bruce R. Blazar, MD, Jeffrey S. Miller, MD, Michael R. Verneris, MD

Blood (2007) 110 (11): 61.

https://doi.org/10.1182/blood.V110.11.61.61

Published: 2007

Journal Articles

The unexpected effect of cyclosporin A on CD56 + CD16 − and CD56 + CD16 + natural killer cell subpopulations

Hongbo Wang, Bartosz Grzywacz, David Sukovich, Valarie McCullar, Qing Cao, Alisa B. Lee, Bruce R. Blazar, David N. Cornfield, Jeffrey S. Miller, Michael R. Verneris

Blood (2007) 110 (5): 1530–1539.

https://doi.org/10.1182/blood-2006-10-048173

Published: 2007

Journal Articles

Coordinated acquisition of inhibitory and activating receptors and functional properties by developing human natural killer cells

Bartosz Grzywacz, Nandini Kataria, Magdalena Sikora, Robert A. Oostendorp, Elaine A. Dzierzak, Bruce R. Blazar, Jeffrey S. Miller, Michael R. Verneris

Blood (2006) 108 (12): 3824–3833.

https://doi.org/10.1182/blood-2006-04-020198

Published: 2006

NARROW

A Mouse Model of CD19 CAR - T Cell Therapy Reveals Mechanism of Cytopenia

Proteomic and Transcriptomic Profiling Reveals Insights into Mechanisms of Leukemic Immune Escape

Gda-201, a Novel Metabolically Enhanced Allogeneic Natural Killer (NK) Cell Product Yields High Remission Rates in Patients with Relapsed/Refractory Non-Hodgkin Lymphoma (NHL): 2-Year Survival and Correlation with Cytokine IL7

Results of a Phase 1 Trial of Gda-201, Nicotinamide-Expanded Allogeneic Natural Killer (NK) Cells in Patients with Refractory Non-Hodgkin Lymphoma (NHL) and Multiple Myeloma

Results of a Phase 1 Trial of Gda-201, Nicotinamide-Expanded Allogeneic Natural Killer Cells (NAM-NK) in Patients with Refractory Non-Hodgkin Lymphoma (NHL) and Multiple Myeloma (MM)

NK Cell Homing and Persistence in Bone Marrow after Adoptive Immunotherapy Correlates with Therapy Response

Specific KIR and HLA Genotypes Affect Outcomes Of Single-Agent Anti-CD20 Immunotherapy Of Follicular Lymphoma

Natural killer–cell differentiation by myeloid progenitors

Limited role of MHC class I chain–related gene A (MICA) typing in assessing graft-versus-host disease risk after fully human leukocyte antigen–matched unrelated donor transplantation

Human embryonic stem cells differentiate into a homogeneous population of natural killer cells with potent in vivo antitumor activity

Identification of a Myeloid Pathway of NK Cell Development and a Myeloid- NK Cell Precursor

Umbilical Cord Blood T Cells Express the Natural Cytotoxicity Receptors, NKp30, NKp44 and NKp46 after IL-15 Stimulation, but Only NKp30 Is Functional.

The unexpected effect of cyclosporin A on CD56 + CD16 − and CD56 + CD16 + natural killer cell subpopulations

Coordinated acquisition of inhibitory and activating receptors and functional properties by developing human natural killer cells

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only